Cardiol Therapeutics (CRDL) Other Non Operating Income: 2020-2021
Historic Other Non Operating Income for Cardiol Therapeutics (CRDL) over the last 2 years, with Dec 2021 value amounting to $1.5 million.
- Cardiol Therapeutics' Other Non Operating Income rose 2201.10% to $2.3 million in Q3 2022 from the same period last year, while for Sep 2022 it was $4.0 million, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2021, which is 5969.96% up from last year.
- Per Cardiol Therapeutics' latest filing, its Other Non Operating Income stood at $1.5 million for FY2021, which was up 5,969.96% from -$25,720 recorded in FY2020.
- Cardiol Therapeutics' 5-year Other Non Operating Income high stood at $1.5 million for FY2021, and its period low was -$25,720 during FY2020.
- Its 2-year average for Other Non Operating Income is $742,015, with a median of $742,015 in 2020.
- Data for Cardiol Therapeutics' Other Non Operating Income shows a peak YoY soared of 5,969.96% (in 2021) over the last 5 years.
- Cardiol Therapeutics' Other Non Operating Income (Yearly) stood at -$25,720 in 2020, then skyrocketed by 5,969.96% to $1.5 million in 2021.